AstraZeneca to cap out-of-pocket inhaler costs in US, following …

March 18 (Reuters) - Drugmaker AstraZeneca (AZN.L) said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, following a ...

CouponFollow Extension

$35
OFF

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

2 weeks from now

reuters.com

$35
OFF

AstraZeneca Caps Patient Out-of-pocket Costs At $35 Per Month …

2 weeks from now

Mar 18, 2024 · AstraZeneca announced it will expand the savings programs for its entire US inhaled respiratory portfolio, helping eligible patients pay no more than $35 per month for their …

astrazeneca-us.com

$35
OFF

Following Boehringer's Lead, AstraZeneca ⁠caps Monthly Out-of …

2 weeks from now

Mar 18, 2024 · The plan is to cap monthly out-of-pocket inhaler costs for eligible patients at $35. The move will kick in on June 1 and includes inhaled medicines for both asthma and chronic …

fiercepharma.com

$35
OFF

AstraZeneca Caps Patient Out-of-pocket Costs At $35 Per Month …

2 weeks from now

WILMINGTON, Del., March 18, 2024--AstraZeneca announced it will expand the savings programs for its entire US inhaled respiratory portfolio, helping eligible patients pay no more …

yahoo.com

$35
OFF

GSK Joins AstraZeneca, Boehringer In Capping US Out-of-pocket …

2 weeks from now

Mar 21, 2024 · Each drugmaker is capping out-of-pocket costs at $35 per month for their respective inhaler products. GSK's new price cap will take effect no later than January 1, …

fiercepharma.com

$35
OFF

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

2 weeks from now

Mar 18, 2024 · AZN. (Reuters) -Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from …

yahoo.com

$35
OFF

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US

2 weeks from now

Mar 21, 2024 · TEVA. GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by …

yahoo.com

$35
OFF

AstraZeneca And GSK Reduce Out-of-Pocket Cost For All Inhaled …

2 weeks from now

Mar 29, 2024 · These announcements from AstraZeneca and GSK follow an earlier announcement on March 7, 2024 from BI who stated it will cap the OOP costs at $35 per …

proactrx.com

$35
OFF

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

2 weeks from now

(Reuters) -Drugmaker AstraZeneca (NASDAQ: AZN) said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, …

investing.com

$35
OFF

AstraZeneca To Cap US Out-of-pocket Costs For Inhalers To $35

2 weeks from now

Mar 18, 2024 · (Reuters) - AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products for chronic lung disease and asthma to $35 per month, starting …

marketscreener.com

$35
OFF

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

2 weeks from now

Mar 18, 2024 · Drugmaker AstraZeneca AZN said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, following a …

tradingview.com

FAQs about AstraZeneca to cap out-of-pocket inhaler costs in US, following … Coupon?

Will AstraZeneca cap out-of-pocket costs?

AstraZeneca announced on Monday that it will cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June. This move follows a similar decision by rival Boehringer Ingelheim earlier in the month. ...

Are AstraZeneca & Boehringer Ingelheim caping out-of-pocket costs?

Anglo-Swedish drugmaker AstraZeneca (AZN.L) and Germany's Boehringer Ingelheim said earlier this month they would cap out-of-pocket costs for their inhaled respiratory products at $35 per month in the U.S. from June. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here. ...

What is AstraZeneca's $35 cap on inhalers?

This $35 cap on inhalers is a part of AstraZeneca’s expanded savings programs. Per management, this program has been launched with the intent to make its inhalers more affordable for patients living with asthma and chronic obstructive pulmonary disease (COPD). The program would also cover patients who are uninsured or underinsured. ...

Can AstraZeneca and Boehringer Ingelheim cap the cost of inhalers?

According to Sanders, if AstraZeneca and Boehringer Ingelheim can cap the cost of their inhalers at $35 per month in the United States, other companies can do the same. Copyright 2024 Nexstar Media Inc. All rights reserved. ...

How much does AstraZeneca cost in 2024?

Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products in 2024. ...

How much does AstraZeneca cost per month?

It is critical that Congress bring together key stakeholders to help reform the healthcare system so patients can afford the medicines they need, not just today, but for the future.” Starting June 1, 2024, eligible patients will pay no more than $35 per month for all AstraZeneca US inhaled respiratory medicines, including: ...